Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETErmining the funCTional Significance of Intermediate Stenoses in isCHEMIc heArt Disease (DETECT ISCHEMIA): Diagnostic Agreement of iFR and QFR.

NCT03420131 is registered in ClinicalTrials.gov with Contilia Clinical Research Institute as lead sponsor.

NCT NCT03420131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03420131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETErmining the funCTional Significance of Intermediate Stenoses in isCHEMIc heArt Disease (DETECT ISCHEMIA): Diagnostic Agreement of iFR and QFR.
Lead sponsor
Contilia Clinical Research Institute
Phase
Observational
Overall status
Unknown status
Start date
July 18, 2017
Completion date
October 1, 2018
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, fractional flow reserve, myocardial